MeiraGTx Holdings (MGTX) Assets Average (2018 - 2025)
MeiraGTx Holdings (MGTX) reported Assets Average of $217.0 million for Q4 2025, down 23.78% on a YoY basis from $284.6 million in Q4 2024, and up 11.78% quarter-over-quarter from $194.1 million in Q3 2025.
MeiraGTx Holdings (MGTX) Assets Average (2018 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Assets Average for 8 years, with the latest figure at $217.0 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average fell 23.78% year-over-year to $217.0 million; the trailing twelve-month figure through Dec 2025 stood at $217.0 million (down 23.78% YoY), and the FY2025 full-year result was $257.1 million, down 13.8% from the prior year.
- Assets Average for Q4 2025 stood at $217.0 million, up from $194.1 million in the prior quarter.
- The five-year high for Assets Average was $351.7 million in Q1 2021, with the low at $194.1 million in Q3 2025.
- Historically, Assets Average has averaged $285.2 million across 5 years, with a median of $292.8 million in 2023.
- Annual changes were most pronounced in 2021 — Assets Average rose 11.95% — and 2025, when it plunged 31.43%.
- MeiraGTx Holdings' Assets Average stood at $311.8 million in 2021, then decreased by 0.62% to $309.8 million in 2022, then decreased by 4.15% to $297.0 million in 2023, then fell by 4.16% to $284.6 million in 2024, then slipped by 23.78% to $217.0 million in 2025.
- The last three Assets Average figures came in at $217.0 million (Q4 2025), $194.1 million (Q3 2025), and $211.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 216.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 216.95 Mn |
| Sep 30, 2025 | 194.09 Mn |
| Jun 30, 2025 | 211.37 Mn |
| Mar 31, 2025 | 246.88 Mn |
| Dec 31, 2024 | 284.62 Mn |
| Sep 30, 2024 | 283.07 Mn |
| Jun 30, 2024 | 287.94 Mn |
| Mar 31, 2024 | 317.99 Mn |
| Dec 31, 2023 | 296.97 Mn |
| Sep 30, 2023 | 288.73 Mn |
| Jun 30, 2023 | 299.20 Mn |
| Mar 31, 2023 | 303.19 Mn |
| Dec 31, 2022 | 309.82 Mn |
| Sep 30, 2022 | 276.94 Mn |
| Jun 30, 2022 | 270.08 Mn |
| Mar 31, 2022 | 303.93 Mn |
| Dec 31, 2021 | 311.75 Mn |
| Sep 30, 2021 | 315.05 Mn |
| Jun 30, 2021 | 333.22 Mn |
| Mar 31, 2021 | 351.69 Mn |